Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors

被引:37
作者
Hintze, Justin M. [1 ]
Ludlow, Christy L. [2 ]
Bansberg, Stephen F. [3 ]
Adler, Charles H. [4 ]
Lott, David G. [1 ,3 ]
机构
[1] Mayo Clin Arizona, Ctr Regenerat Med, Head & Neck Regenerat Program, Phoenix, AZ 85054 USA
[2] James Madison Univ, Dept Commun Sci & Disorders, Harrisonburg, VA 22807 USA
[3] Mayo Clin Arizona, Dept Otorhinolaryngol, Phoenix, AZ 85054 USA
[4] Mayo Clin Arizona, Dept Neurol, Phoenix, AZ 85054 USA
关键词
spasmodic dysphonia; laryngeal dystonia; pathogenesis; etiology; BOTULINUM TOXIN; LARYNGEAL DYSTONIA; RISK-FACTORS; PATHOPHYSIOLOGY; DISCRIMINATION; EXPERIENCE; PATIENT; CLASSIFICATION; STIMULATION; INJECTIONS;
D O I
10.1177/0194599817728521
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective. The purpose of this review is to describe the recent advances in identifying possible factors involved in the pathogenesis of spasmodic dysphonia. Spasmodic dysphonia is a task-specific focal laryngeal dystonia characterized by irregular and uncontrolled voice breaks. Pathogenesis of the disorder is poorly understood. Data Sources. PubMed, Google Scholar, and Cochrane Library. Review Methods. The data sources were searched using the following search terms: (spasmodic dysphonia or laryngeal dystonia) and (etiology, aetiology, diagnosis, pathogenesis, or pathophysiology). Conclusions. Several potential etiological factors have been proposed by epidemiological, genetic, and neuropathological studies. Spasmodic dysphonia is a rare disorder primarily affecting females beginning in their 40s. Vocal tremor co-occurs in 30% to 60%. Large cohort studies identified risk factors such as a family history of neurological disorders including dystonia and tremor, recent viral illness, and heavy voice use. As none are rare events, a complex interactive process may contribute to pathogenesis in a small proportion of those at risk. Consequences to pathogenesis are neurological processes found in spasmodic dysphonia: loss of cortical inhibition, sensory processing disturbances, and neuroanatomical and physiological differences in the laryngeal motor control system. Implications for Practice. Diagnosis of spasmodic dysphonia usually includes speech and laryngoscopic assessment. However, as diagnosis is sometimes problematic, measurement of neurophysiological abnormalities may contribute useful adjuncts for the diagnosis of spasmodic dysphonia in the future.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 53 条
  • [1] Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia
    Adams, SG
    Durkin, LC
    Irish, JC
    Wong, DLH
    Hunt, EJ
    [J]. LARYNGOSCOPE, 1996, 106 (03) : 296 - 300
  • [2] Female predominance in spasmodic dysphonia
    Adler, CH
    Edwards, BW
    Bansberg, SF
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (05) : 688 - 688
  • [3] Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia
    Adler, CH
    Bansberg, SF
    Krein-Jones, K
    Hentz, JG
    [J]. MOVEMENT DISORDERS, 2004, 19 (09) : 1075 - 1079
  • [4] Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia:: An H215OPET study
    Ali, S. Omar
    Thomassen, Michael
    Schulz, Geralyn M.
    Hosey, Lara A.
    Varga, Mary
    Ludlow, Christy L.
    Braun, Allen R.
    [J]. JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 2006, 49 (05): : 1127 - 1146
  • [5] Neurophysiological Correlates of Abnormal Somatosensory Temporal Discrimination in Dystonia
    Antelmi, Elena
    Erro, Roberto
    Rocchi, Lorenzo
    Liguori, Rocco
    Tinazzi, Michele
    Di Stasio, Flavio
    Berardelli, Alfredo
    Rothwell, John C.
    Bhatia, Kailash P.
    [J]. MOVEMENT DISORDERS, 2017, 32 (01) : 141 - 148
  • [6] Dystonia: an update on phenomenology, classification, pathogenesis and treatment
    Balint, Bettina
    Bhatia, Kailash P.
    [J]. CURRENT OPINION IN NEUROLOGY, 2014, 27 (04) : 468 - 476
  • [7] Spatial discrimination is abnormal in focal hand dystonia
    Bara-Jimenez, W
    Shelton, P
    Hallett, M
    [J]. NEUROLOGY, 2000, 55 (12) : 1869 - 1873
  • [8] Effects of botulinum toxin on pathophysiology in spasmodic dysphonia
    Bielamowicz, S
    Ludlow, CL
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2000, 109 (02) : 194 - 203
  • [9] Semon's law revisited: An electromyographic analysis of laryngeal synkinesis
    Blitzer, A
    Jahn, AF
    Keidar, A
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1996, 105 (10) : 764 - 769
  • [10] Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series
    Blitzer, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 28 - 30